SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-13-004261
Filing Date
2013-08-14
Accepted
2013-08-14 08:21:57
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0613_yewbio.htm 10-Q 1312203
2 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB f10q0613ex31i_yewbio.htm EX-31.1 9650
3 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB f10q0613ex31ii_yewbio.htm EX-31.2 9586
4 CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE CHIEF EXECUTIVE OFFICER AND CH f10q0613ex32_yewbio.htm EX-32 5167
  Complete submission text file 0001213900-13-004261.txt   8850192

Data Files

Seq Description Document Type Size
5 yewb-20130630.xml EX-101.INS 964522
6 yewb-20130630.xsd EX-101.SCH 55559
7 yewb-20130630_cal.xml EX-101.CAL 37437
8 yewb-20130630_def.xml EX-101.DEF 93235
9 yewb-20130630_lab.xml EX-101.LAB 383127
10 yewb-20130630_pre.xml EX-101.PRE 234230
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 131035027
SIC: 0100 Agricultural Production-Crops